Polymeric diffusion matrix containing propranolol
US4460562A · kind A · utility
59Cited by
15References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 1983 |
| Grant date | Jul 17, 1984 |
| Priority date | — |
| Expiry date | Mar 30, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver the propranolol to a patient. The matrix comprises from about 1 to about 60% of a polar plasticizer, from about 6 to about 30% by weight polyvinylalcohol, from about 2 to about 30% by weight polyvinylpyrrolidone, and a pharmaceutically effective amount of propranolol to provide a sustained release of propranolol over a prolonged period.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.